RB
EW icon

Renasant Bank’s Edwards Lifesciences EW Stock Holding History

Renasant Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,459
Closed -$309K – 174
2023
Q3 		$309K Sell
4,459
-366
-8% -$29.4K 0.26% 117
2023
Q2 		$455K Sell
4,825
-693
-13% -$60.2K 0.37% 85
2023
Q1 		$457K Sell
5,518
-1,032
-16% -$81.1K 0.35% 94
2022
Q4 		$489K Buy
6,550
+1,147
+21% +$88.4K 0.37% 94
2022
Q3 		$446K Buy
5,403
+738
+16% +$71K 0.39% 92
2022
Q2 		$444K Sell
4,665
-28
-0.6% -$2.9K 0.36% 91
2022
Q1 		$553K Buy
4,693
+35
+0.8% +$3.93K 0.37% 85
2021
Q4 		$604K Sell
4,658
-11
-0.2% -$1.28K 0.41% 73
2021
Q3 		$528K Hold
4,669
– – 0.42% 77
2021
Q2 		$484K Sell
4,669
-172
-4% -$16.2K 0.37% 87
2021
Q1 		$405K Sell
4,841
-116
-2% -$9.81K 0.33% 101
2020
Q4 		$452K Buy
+4,957
New +$411K 0.37% 86

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Renasant Bank's EW Position: Q4 2023 in Review

Renasant Bank sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 4,459 shares — an estimated $309K sold.

Renasant Bank first reported a position in EW in Q4 2020 and held it in 12 quarters. The position peaked at $604K in Q4 2021. 1,245 funds tracked by Wall St. Rank hold EW as of Q4 2023.

  • Renasant Bank reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
  • Renasant Bank sold 4,459 Edwards Lifesciences shares in Q4 2023, an estimated $309K.
  • Renasant Bank first reported a position in Edwards Lifesciences in Q4 2020 and held it in 12 quarters.
  • Renasant Bank's Edwards Lifesciences position peaked at $604K in Q4 2021.
  • 1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Renasant Bank's 13F filing for Q4 2023, filed 12 Feb 2024.